Latest filing published 07 Aug 2026 for Corbus Pharmaceuticals Holdings, Inc., €149k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Stifel, Nicolaus & Company, Inc CIAS /FA: trading record in brief
Stifel, Nicolaus & Company, Inc CIAS /FA appears in our data through filings on Corbus Pharmaceuticals Holdings, Inc. shares, published by SEC (Form 4). Activity is concentrated on a single trading day, 7 August 2026, with 2 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 7 August 2026, reports a transaction of €149k in Corbus Pharmaceuticals Holdings, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Stifel, Nicolaus & Company, Inc CIAS /FA
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 17,000 shares@ US$10.0821Common StockSEC144:0001972481-26-000254
- 12,000 shares@ US$10.0809Common StockSEC144:0001972481-26-000255
2 of 2 declarations